AKT1 and esophageal squamous cell carcinoma: These molecules can directly or indirectly regulate the PI3K/Akt/mTOR pathway through a variety of ways, thereby affecting the proliferation, metastasis, chemoradiotherapy sensitivity and angiogenesis of ESCC.